InvestorsHub Logo

ash111

11/23/16 5:00 PM

#728 RE: Irishtrader1 #725

ACAN-great DD.,Impressive Resume:
Tim Keogh, President, CEO
Mr. Keogh offers a unique combination of firsthand experience in the cannabis industry, from licensing to operations in numerous states, and an extensive background in real estate development. He is a director of one of fifteen Provisionally Registered marijuana dispensaries in Massachusetts, a board member of the Cannabis Producers Association of New England, and an active member and invited speaker for the National Cannabis Industry Association. He received a BS in business administration from Mount St. Mary’s College.

Ben Barton, Founder, Director, CFO
Mr. Barton has been the managing director of a Colorado-based venture capital and private equity firm since 2006. He has extensive experience in the public and private capital markets, and has been instrumental in raising of over $800 million in equity and debt financing for emerging companies over the past decade. He earned an MBA in finance from UCLA.

Brian E. Corr, Ph.D, Horticultural Advisor
Most recently Dr. Corr managed a technical team for Syngenta responsible for providing technical advice to greenhouse facilities throughout North America. In the past he has been a faculty member at the University of Tennessee specializing in controlled-environment horticulture. Later, at the Ball Horticultural Company, he managed a research greenhouse, directed research, had responsibility for international sales and was Director of New Crop Development. In his position with Valent Biosciences he introduced a new organically-certified plant growth regulator for grape production.

D. Michael Anderson, Ph.D, Medical Advisor
Dr. Anderson has over 25 years’ experience in public health research design and ethics. He has been a leader in the review, funding, and commercialization of behavioral research and development, including tech-based applications for health promotion and disease prevention. Dr. Anderson was a Project Director at the National Cancer Institute (NCI;NIH) and is currently the & Human Subjects Protections Administrator for the Federally-authorized Health Media Lab Institutional Review Board (IRB) in Washington, DC. He received his Ph.D. and MPH at the University Of Minnesota School Of Public Health.

mc67

11/25/16 11:46 AM

#743 RE: Irishtrader1 #725

Good post Irishtrader1, Hang in there ash111 ;)

I've watched AmeriCann and owned the stock since its first capital raise at $.75 in early 2014. (Americann.co)

Everyone focuses on ACAN's
Massachusetts cultivation center and that's justified given the huge size, (25 football fields in size when all built out) the appeal of the Massachusetts market and the potential impact to the company.

But this is also -beyond Massachusetts-a company with a very serious management team that was an early entrant into the cannabis industry in Colorado. They have $2 million invested in land they own in Colorado and $1 million in an Illinois cultivation center. They invested $1 million in a cultivation operation in Colorado in 2014 and have gotten all their investment back plus $300,000 more.

This is all in their public filings.

Management has put up over $5 million of their own capital in building the business and ACAN completed a broker dealer led $2 million equity raise just before the election so they have a nice cash position. (Unlike most cannabis companies).

They have spent over $1.4 million and two years getting the giant MMCC proposed project zoned and approved and that looks real smart now. Massachusetts is going to need millions of square feet of cultivation capacity.

ACAN has a well structured capitalization with under 20 million shares outstanding and no cheap options or toxic debt.

And their market value is under $30 million while many clearly inferior public companies have much higher valuations.

Do your own research and DD and you'll see why people that know the industry like this company and what they are doing.

They have very ambitious long term national plans and if they succeed the shareholders will be very well rewarded.

ash111

12/02/16 3:15 PM

#806 RE: Irishtrader1 #725

That's the main reason I'm in. Pretty rare to see management that investing from their own money. If they believe ACAN I believe more investors will follow.